| Drug Name | REMINYL (Galantamine Hydromromide) |
|---|---|
| Drug Class |
Antipsychotic
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Psychiatry
|
| Risk |
New safety information regarding the risk of serious skin reactions associated with the use of REMINYL® (galantamine hydrobromide) |
| Dear Healthcare provider letter DHPC |
|